Head-to-head · WeighScore
You + Me (He & She MD) vs RxSpan MD
By GLP-1 ScorecardUpdated
Score comparison
RxSpan MD has the higher recorded score — 84.3/100 to 71.5/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Before you choose
RxSpan MD does not publish a tirzepatide price, so its RxSpan MD review sets out what it does disclose, while the You + Me (He & She MD) review explains the conditions attached to You + Me (He & She MD)'s figure. The tirzepatide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.
If neither one fits, You + Me (He & She MD) vs Semaglutide Online and Healthicare vs RxSpan MD compare each of them with another graded program, and the list of alternatives to You + Me (He & She MD) ranks the programs closest to You + Me (He & She MD) on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | You + Me (He & She MD) | RxSpan MD |
|---|---|---|
| WeighScore | 71.5/100 | 84.3/100 |
| Grade | C | B |
| Site position | #100 | #4 |
| Semaglutide | Conflicting promotional terms | Current compounded quote unconfirmed |
| Tirzepatide | $159/mo (advertised promotion, selected quote required) | Current compounded quote unconfirmed |
| Coverage | Confirm treatment availability by state | Confirm treatment availability during intake |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Describes clinician access, coaching and progress tracking.
- Publishes a plan-specific cancellation FAQ.
What to consider
- Confirm which promotion and renewal apply to the selected term.
- The FAQ describes prepaid plans as generally nonrefundable after approval and payment.
Site position #4 · B
Strengths
- Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
- Public terms describe independent healthcare providers
- Homepage describes messaging and care-team appointments
What to consider
- Homepage advertises compounded plans that the current catalog did not substantiate
- Current oral GLP-1 availability is unconfirmed
- Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
- Public terms do not establish unused prepaid-treatment refund amounts
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.